1. Home
  2. PRTA vs MTUS Comparison

PRTA vs MTUS Comparison

Compare PRTA & MTUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • MTUS
  • Stock Information
  • Founded
  • PRTA 2012
  • MTUS 1899
  • Country
  • PRTA Ireland
  • MTUS United States
  • Employees
  • PRTA N/A
  • MTUS N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • MTUS
  • Sector
  • PRTA Health Care
  • MTUS
  • Exchange
  • PRTA Nasdaq
  • MTUS NYSE
  • Market Cap
  • PRTA 809.8M
  • MTUS 699.0M
  • IPO Year
  • PRTA N/A
  • MTUS N/A
  • Fundamental
  • Price
  • PRTA $9.20
  • MTUS $12.97
  • Analyst Decision
  • PRTA Buy
  • MTUS
  • Analyst Count
  • PRTA 9
  • MTUS 0
  • Target Price
  • PRTA $54.57
  • MTUS N/A
  • AVG Volume (30 Days)
  • PRTA 572.3K
  • MTUS 383.8K
  • Earning Date
  • PRTA 05-07-2025
  • MTUS 05-08-2025
  • Dividend Yield
  • PRTA N/A
  • MTUS N/A
  • EPS Growth
  • PRTA N/A
  • MTUS N/A
  • EPS
  • PRTA N/A
  • MTUS 0.03
  • Revenue
  • PRTA $135,157,000.00
  • MTUS $1,084,000,000.00
  • Revenue This Year
  • PRTA N/A
  • MTUS $9.13
  • Revenue Next Year
  • PRTA $131.71
  • MTUS $10.82
  • P/E Ratio
  • PRTA N/A
  • MTUS $420.11
  • Revenue Growth
  • PRTA 47.92
  • MTUS N/A
  • 52 Week Low
  • PRTA $9.10
  • MTUS $10.78
  • 52 Week High
  • PRTA $25.42
  • MTUS $24.31
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 26.58
  • MTUS 48.38
  • Support Level
  • PRTA $9.30
  • MTUS $12.45
  • Resistance Level
  • PRTA $10.45
  • MTUS $12.89
  • Average True Range (ATR)
  • PRTA 0.81
  • MTUS 0.68
  • MACD
  • PRTA -0.15
  • MTUS 0.10
  • Stochastic Oscillator
  • PRTA 2.77
  • MTUS 72.28

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About MTUS METALLUS INC

Metallus Inc is an America-based manufacturer of alloy steel, as well as carbon and micro-alloy steel. The portfolio of the company includes special bar quality steel, seamless mechanical tubes, and value-add solutions, such as precision steel components. The company also supplies machining and thermal treatment services and manages raw material recycling programs that work as a feeder system for its melt operations. The company's products and services are used in the following sectors: oil and gas; automotive; industrial equipment; mining; construction; rail; aerospace and defense; heavy truck; agriculture; and power generation. Geographically, the company mainly serves customers in the United States.

Share on Social Networks: